Loss of heterozygosity analysis on chromosome 5p defines 5p13-12 as the critical region involved in tumor progression of bladder carcinomas

International Journal of Cancer

Volumn 86, Issue 3, 2000, Pages 194-197

  Böhm, Malte ^a   Kleine Besten, Rainer ^b   Wieland, Ilse ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BLADDER CARCINOMA; CELL DIFFERENTIATION; CHROMOSOME 5P; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; BLADDER TUMOR; CANCER STAGING; CHROMOSOME 5; DISEASE COURSE; GENETICS; PATHOLOGY;

MICROSATELLITE DNA;

ALLELES; CHROMOSOMES, HUMAN, PAIR 5; DISEASE PROGRESSION; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 0034688908     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(20000320)89:2<194::aid-ijc15>3.0.co;2-s     Document Type: Article

References (36)

1. ALBERTSEN, H.M., SMITH, S.A., MELIS, R., WILLIAMS, B., HOLIK, P., STEVENS, J. and WHITE, R., Sequence, genomic structure, and chromosomal assignment of human DOC-2. Genomics, 33, 207-213 (1996).
2. + cell cycle checkpoint control gene. Genomics, 54, 331-337 (1998).
3. BÖHM, M., KIRCH, H., OTTO, T., RÜBBEN, H. and WIELAND, I., Deletion analysis at the del-27, APC and MTS1 loci in bladder cancer: LOH at the del-27 locus on 5p13-12 is a prognostic marker of tumor progression. Int. J. Cancer, 74, 291-295 (1997a).
4. BÖHM, M. and WIELAND, I., Analysis of tumour-specific alterations in native specimens by PCR: how to procure the tumour cells? Int. J. Oncol., 10, 131-139 (1997).
5. BÖHM, M., WIELAND, I., SCHÜTZE, K. and RÜBBEN, H., Microbeam-MOMeNT: non-contact laser microdissection of membrane-mounted native tissue. Amer. J. Pathol., 151, 63-67 (1997b).
6. CAIRNS, P., MAO, L., MERLO, A., LEE, D.J., SCHWAB, D., EBY, Y., TOKINO, K., VAN DER RIET, P., BLAUGRUND, J.E. and SIDRANSKY, D., Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science, 265, 415-416 (1994).
7. CALIFANO, J.A., JOHNS III, M.M., WESTRA, W.H., LANGO, M.N., EISELE, D., SAJI, M., ZEIGER, M.A., UDELSMAN, R., KOCH, W.M. and SIDRANSKY, D., An allelotype of papillary thyroid cancer. Int. J. Cancer, 69, 442-444 (1996).
8. DALBAGNI, G., PRESTI, J., REUTER, V., FAIR, W.R. and CORDON-CARDO, C., Genetic alterations in bladder cancer. Lancet, 342, 469-471 (1993).
9. DEAN, F.B., LIAN, L. and O'DONNELL, M., cDNA cloning and gene mapping of human homologs for Schizosaccharomyces pombe rad17, rad1, and hus1 and cloning of homologs from mouse, Caenorhabditis elegans, and Drosophila melanogaster. Genomics, 54, 424-436 (1998).
10. DEISS, L.P., FEINSTEIN, E., BERISSI, H., COHEN, O. and KIMCHI, A., Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Develop., 9, 15-30 (1995).
11. DIB, C. and 13 OTHERS, A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond.), 380, 152-154 (1996).
12. EL-NAGGAR, A.K., ABDUL-KARIM, F.W., HURR, K., CALLENDER, D., LUNA, M.A. and BATSAKIS, J.G., Genetic alterations in acinic cell carcinoma of the parotid gland determined by microsatellite analysis. Cancer Genet. Cytogenet., 102, 19-24 (1998).
13. FEINSTEIN, E., DRUCK, T., KASTURY, K., BERISSI, H., GOODART, S.A., OVERHAUSER, J., KIMCHI, A. and HUEBNER, K., Assignment of DAP1 and DAPK - genes that positively mediate programmed cell death triggered by IFN-gamma - to chromosome region 5p12.2 and 9q34.1, respectively. Genomics, 29, 305-307 (1995).
14. FOLKMAN, J. and MOSCONA, A., A role of cell shape in growth control. Nature (Lond.), 273, 345-349 (1978).
15. + and Saccharomyces cerevisiae RAD17: linkage to checkpoint control and mammalian meiosis. Genes Develop., 12, 2560-2573 (1998).
16. HOFF III, H.B., TRESINI, M., LI, S. and SELL, C., DBI-1, a novel gene related to the notch family, modulates mitogenic response to insulin-like growth factor 1. Exp. Cell Res., 238, 359-370 (1998).
17. HOVEY, R., CHU, L., BALAZS, M., DEVRIES, S., MOORE, D., SAUTER, G., CARROLL, P.R. and WALDMAN, F.M., Genetic alterations in primary bladder cancers and their metastases. Cancer Res., 58, 3555-3560 (1998).
18. KALLIONIEMI, A., KALLIONIEMI, O., CITRO, G., SAUTER, G., DE VRIES, S., KERSCHMANN, R., CARROLL, P. and WALDMAN, F., Identification of novel DNA amplifications and deletions in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer, 12, 213-219 (1995).
19. KALLIONIEMI, A., KALLIONIEMI, O., SUDAR, D., RUTOVITZ, D., GRAY, J., WALDMAN, F. and PINKEL, D., Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science, 258, 818-821 (1992).
20. KNOWLES, M.A., Molecular genetics of bladder cancer. Brit. J. Urol., 75 (Suppl. 1), 57-66 (1995).
21. KNOWLES, M.A., ELDER, P.A., WILLIAMSON, M., CAIRNS, J.P., SHAW, M.E. and LAW, M.G., Allelotype of human bladder cancer. Cancer Res., 54, 531-538 (1994).
22. MARATHI, U.K., DAHLEN, M., SUNNERHAGEN, P., ROMERO, A.V., RAMAGLI, L.S., SICILIANO, M.J., LI, L. and LEGERSKI, R.J., RAD1, a human structural homolog of the Schizosaccharomyces pombe RAD1 cell cycle checkpoint gene. Genomics, 54, 344-347 (1998).
23. MITRA, A.B., MURTY, V.V.V.S., LI, R.G., PRATAP, M., LUTHRA, U.K. and CHAGANTI, R.S.K., Allelotype analysis of cervical carcinoma. Cancer Res., 54, 4481-4487 (1994).
24. MOK, S.C., CHAN, W.Y., WONG, K.K., CHEUNG, K.K., LAU, C.C., NG, S.W., BALDINI, A., COLITTI, C.V., ROCK, C.O. and BERKOWITZ, R.S., DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene, 16, 2381-2387 (1998).
25. MOSTOFI, F.K., SOBIN, L.H. and TORLONI, H., Histological typing of urinary bladder tumors, World Health Organization, Geneva (1973).
26. OLUMI, A.F., TSAI, Y.C., NICHOLS, P.W., SKINNER, D.G., CAIN, D.R., BENDER, L.I. and JONES, P.A., Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res., 50, 7081-7083 (1990).
27. 1+ checkpoint gene encodes an exonuclease. J. biol. Chem., 273, 18332-18339 (1998).
28. PERALTA, R.C., CASSON, A.G., WANG, R.-N., KESHAVJEE, S., REDSTON, M. and BAPAT, B., Distinct regions of frequent loss of heterozygosity of chromosome 5p and 5q in human esophageal cancer. Int. J. Cancer, 78, 600-605 (1998).
29. RICHTER, J., BEFFA, L., WAGNER, U., SCHRAML, P., GASSER, T.C., MOCH, H., MIHATSCH, M.J. and SAUTER, G., Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Amer. J. Pathol., 153, 1615-1621 (1998).
30. RICHTER, J., JIANG, F., GÖRÖG, J.-P., SARTORIUS, G., EGENTER, C., GASSER, T.C., MOCH, H., MIHATSCH, M.J. and SAUTER, G., Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res., 57, 2860-2864 (1997).
31. UNION INTERNATIONALE CONTRE LE CANCER (UICC), TNM-ATLAS, Springer, Berlin (1993).
32. VOORTER, C., JOOS, S., BRINGUIER, P.P., VALLINGA, M., PODDIGHE, P., SCHALKEN, J., DU MANOIR, S., RAMAEKERS, F., LICHTER, P. and HOPMAN, A., Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Amer. J. Pathol., 146, 1341-1354 (1995).
33. WIELAND, I., ARDEN, K.C., MICHELS, D., KLEIN-HITPASS, L., BÖHM, M., VIARS, C.S. and WEIDLE, U.H., Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas. Oncogene, 18, 4530-4537 (1999).
34. WIELAND, I. and BÖHM, M., Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer. Cancer Res., 54, 1772-1774 (1994).
35. WIELAND, I., BÖHM, M., ARDEN, K.C., AMMERMÜLLER, T., BOGATZ, S., VIARS, C.S. and RAJEWSKY, M.F., Allelic deletion mapping on chromosome 5 in human lung carcinomas. Oncogene, 12, 97-102 (1996).
36. WU, S.Q., STORER, B.E., BOOKLAND, E.A., KLINGELHUTZ, A.J., GILCHRIST, K.W., MEISNER, L.F., OYASU, R. and REZNIKOFF, C.A., Nonrandom chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells. Cancer Res., 51, 3323-3326 (1991).